AMERI, PIETRO
 Distribuzione geografica
Continente #
EU - Europa 1.193
AS - Asia 1.009
NA - Nord America 592
SA - Sud America 147
AF - Africa 41
OC - Oceania 1
Totale 2.983
Nazione #
US - Stati Uniti d'America 566
SG - Singapore 505
IT - Italia 483
RU - Federazione Russa 400
CN - Cina 236
BR - Brasile 109
HK - Hong Kong 87
VN - Vietnam 83
DE - Germania 64
NL - Olanda 51
FR - Francia 35
FI - Finlandia 26
JP - Giappone 23
IN - India 22
PT - Portogallo 21
GB - Regno Unito 18
KR - Corea 16
ES - Italia 15
AR - Argentina 13
LT - Lituania 11
ZA - Sudafrica 11
BE - Belgio 10
CA - Canada 10
MX - Messico 10
TR - Turchia 10
CO - Colombia 8
IE - Irlanda 8
AT - Austria 7
EC - Ecuador 7
PL - Polonia 7
UA - Ucraina 7
EG - Egitto 6
MA - Marocco 6
SE - Svezia 6
CI - Costa d'Avorio 5
PY - Paraguay 5
CH - Svizzera 4
HR - Croazia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
BJ - Benin 3
GE - Georgia 3
PH - Filippine 3
RO - Romania 3
RS - Serbia 3
DZ - Algeria 2
GR - Grecia 2
IL - Israele 2
IQ - Iraq 2
LV - Lettonia 2
NO - Norvegia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UZ - Uzbekistan 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
CL - Cile 1
DO - Repubblica Dominicana 1
FJ - Figi 1
GM - Gambi 1
HN - Honduras 1
JM - Giamaica 1
KZ - Kazakistan 1
LC - Santa Lucia 1
ML - Mali 1
PA - Panama 1
SC - Seychelles 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.983
Città #
Singapore 263
Moscow 100
Hefei 89
Ashburn 87
Hong Kong 87
Beijing 58
Chandler 55
Naples 44
Milan 33
Santa Clara 33
Amsterdam 31
Rome 30
San Jose 28
Los Angeles 22
Palermo 20
Dong Ket 18
Ho Chi Minh City 18
Munich 17
Seoul 16
Hanoi 14
Bologna 11
Millbury 11
Nanjing 11
New York 11
Redondo Beach 11
São Paulo 11
Turin 11
Council Bluffs 10
Montijo 10
Turku 10
Bari 9
Buffalo 9
Napoli 9
The Dalles 9
Denver 8
Helsinki 8
Kochi 8
Lawrence 8
Manfredonia 8
Boston 7
Dallas 7
Des Moines 7
Lappeenranta 7
Tokyo 7
Bogotá 6
Dublin 6
Foggia 6
Ankara 5
Brescia 5
Brooklyn 5
Caserta 5
Chengdu 5
Chicago 5
Collecchio 5
Düsseldorf 5
Houston 5
Maasmechelen 5
Madrid 5
Orem 5
Stockholm 5
Vilnius 5
Belo Horizonte 4
Catania 4
Chennai 4
Dearborn 4
Fairfield 4
Falkenstein 4
Florence 4
Haiphong 4
Locorotondo 4
Oeiras 4
Princeton 4
San Francisco 4
Seattle 4
Toronto 4
Wilmington 4
Zagreb 4
Atlanta 3
Betim 3
Chiyoda-ku 3
Cologne 3
Cotonou 3
Frankfurt am Main 3
Guangzhou 3
Guayaquil 3
Hangzhou 3
Hải Dương 3
Lisbon 3
Lomas de Zamora 3
Montreal 3
Mumbai 3
Paris 3
Perugia 3
Pescara 3
Phoenix 3
Pisa 3
Pisogne 3
Quito 3
Roubaix 3
Shenzhen 3
Totale 1.502
Nome #
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 697
Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis 154
Antineoplastic drug-induced cardiotoxicity: A redox perspective 140
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart 122
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models 119
The role of mitochondrial dynamics in cardiovascular diseases 119
Mitochondrial a Kinase Anchor Proteins in Cardiovascular Health and Disease: A Review Article on Behalf of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology 112
European Society of Cardiology Core Curriculum for Cardio-Oncology 111
Common Mechanistic Pathways in Cancer and Heart Failure 110
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 107
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 107
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) 106
Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge 101
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 97
Priorities in Cardio-Oncology Basic and Translational Science 93
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology 90
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore longitudinal study of aging 88
Distinctive patterns of inflammation across the heart failure syndrome 87
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology 84
Cardiovascular safety of the tyrosine kinase inhibitor nintedanib 77
Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart 72
Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial 70
The Human Fetal and Adult Stem Cell Secretome Can Exert Cardioprotective Paracrine Effects against Cardiotoxicity and Oxidative Stress from Cancer Treatment 49
Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases 49
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology 26
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 16
Implementation of guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa‐HF Registry) 13
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy 9
Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis 5
The ETNA-AF Europe Registry: 4-year data of edoxaban use in atrial fibrillation in the Italian real world compared to the European cohort 1
Totale 3.031
Categoria #
all - tutte 8.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 5 1 1 5 3 20
2021/202265 0 0 0 2 1 5 1 9 1 7 15 24
2022/2023487 13 14 40 34 42 35 46 67 103 61 22 10
2023/2024285 15 20 39 25 20 45 25 23 8 20 23 22
2024/2025970 34 54 11 20 30 80 79 71 61 89 355 86
2025/20261.115 172 149 190 176 269 96 63 0 0 0 0 0
Totale 3.031